PMC:7784830 / 4713-5115 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"86","span":{"begin":67,"end":71},"obj":"Chemical"},{"id":"87","span":{"begin":162,"end":167},"obj":"Chemical"},{"id":"88","span":{"begin":229,"end":235},"obj":"Chemical"},{"id":"89","span":{"begin":320,"end":324},"obj":"Chemical"}],"attributes":[{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"MESH:D008055"},{"id":"A88","pred":"tao:has_database_id","subj":"88","obj":"MESH:D012822"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Drugs are either directly introduced [25–28] in the formulation of ODFs or size reduced and converted to solid dispersions [29] or nanoparticles [30,31] or solid lipid microparticles [32] or micronized and surface modified using silica [33] which not only help in enhancing the amount of drug that could be loaded on to ODFs but also help in enhancing the release rate and, bioavailability of the drug."}

{"project":"LitCovid-sentences","denotations":[{"id":"T45","span":{"begin":0,"end":402},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Drugs are either directly introduced [25–28] in the formulation of ODFs or size reduced and converted to solid dispersions [29] or nanoparticles [30,31] or solid lipid microparticles [32] or micronized and surface modified using silica [33] which not only help in enhancing the amount of drug that could be loaded on to ODFs but also help in enhancing the release rate and, bioavailability of the drug."}